Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.7500
-0.0294 (-3.77%)
At close: Oct 31, 2025, 4:00 PM EDT
0.7474
-0.0026 (-0.35%)
After-hours: Oct 31, 2025, 7:59 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $121.28 million as of October 31, 2025. Its market cap has decreased by -4.65% in one year.
Market Cap
121.28M
Enterprise Value
11.67M
1-Year Change
-4.65%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $121.28M, a decrease of -59.80%. That is a compound annual growth rate of -16.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 126.03M | 44.21% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |